HomeOGN • NYSE
add
Organon & Co
Previous close
$8.77
Day range
$8.76 - $9.05
Year range
$8.01 - $23.10
Market cap
2.35B USD
Avg Volume
7.24M
P/E ratio
3.13
Dividend yield
0.88%
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.51B | -6.72% |
Operating expense | 516.00M | -4.97% |
Net income | 87.00M | -56.72% |
Net profit margin | 5.75 | -53.59% |
Earnings per share | 1.02 | -16.39% |
EBITDA | 409.00M | -14.61% |
Effective tax rate | 13.86% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 547.00M | -4.87% |
Total assets | 13.16B | 10.64% |
Total liabilities | 12.61B | 6.51% |
Total equity | 542.00M | — |
Shares outstanding | 259.96M | — |
Price to book | 4.18 | — |
Return on assets | 6.19% | — |
Return on capital | 8.55% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 87.00M | -56.72% |
Cash from operations | 75.00M | -1.32% |
Cash from investing | -172.00M | -79.17% |
Cash from financing | -75.00M | -1.35% |
Net change in cash | -128.00M | -8.47% |
Free cash flow | -73.38M | -288.75% |
About
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Wikipedia
Founded
1923
Headquarters
Website
Employees
10,000
